Vunakizumab

• Catalog Number: orb1980603
• Category: Antibodies
• Description: Vunakizumab (Anti-Human IL17A Recombinant Antibody) is a human IgGκ monoclonal antibody that specifically targets and inhibits IL-17A's receptor interaction, making it useful for researching autoimmune conditions such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis, and inflammatory arthritis [1].
• Clonality: Recombinant
• CAS Number: 1792181-33-9
• Antibody Type: Recombinant Antibody
• Concentration: 5.2 mg/mL
• Purity: 95.00%
• Conjugation: Unconjugated
• Target: Vunakizumab
• Biological Activity: Vunakizumab is a humanized IgGκ monoclonal antibody targeting IL-17A, which is often linked to interleukin 22 to form Vunakizumab-IL22 for the study of influenza virus-induced lung immune injury Vunakizumab is used in the study of psoriatic arthritis and works by binding to IL-17A.
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Note: For research use only
• Expiration Date: 12 months from date of receipt.